This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Cellectar Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0. Cellectar Biosciences's 10-Year median PS Ratio is . Therefore, the Median PS Value for today is $0.00.
As of today (2024-04-24), Cellectar Biosciences's share price is $3.06. Cellectar Biosciences's Median PS Value is $0.00. Therefore, Cellectar Biosciences's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Cellectar Biosciences's Median PS Value or its related term are showing as below:
CLRB's Price-to-Median-PS-Value is not ranked *
in the Biotechnology industry.
Industry Median: 0.66 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Cellectar Biosciences Median PS Value Historical Data
The historical data trend for Cellectar Biosciences's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cellectar Biosciences's Median PS Value
For the Biotechnology subindustry, Cellectar Biosciences's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cellectar Biosciences's Price-to-Median-PS-Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Cellectar Biosciences's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Cellectar Biosciences's Price-to-Median-PS-Value falls into.
Cellectar Biosciences Median PS Value Calculation
Cellectar Biosciences's Median PS Value for today is calculated as
10-Year Median PS Ratio is .
Cellectar Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cellectar Biosciences (NAS:CLRB) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Cellectar Biosciences's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
3.06
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cellectar Biosciences Median PS Value Related Terms
Thank you for viewing the detailed overview of Cellectar Biosciences's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Cellectar Biosciences (Cellectar Biosciences) Business Description
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and better safety as a result of fewer off-target effects. Its lead PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CLRB has been successfully added to your 